NCT00369889
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
- Locations
-
- Indiana University Cancer Center Indianapolis, Indiana, United States
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,990 public trials
1,836 recruiting studies
Lymphatic Diseases trial results
NCT00314873
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
- Locations
-
- Indiana University Cancer Center Indianapolis, Indiana, United States
Completed
Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath
NCT00580034
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
- Locations
-
- Duke University Health Systems Durham, North Carolina, United States
NCT00142116
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT00597714
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +19 more
- Locations
-
- Duke University Health System Durham, North Carolina, United States
NCT00117988
- Conditions
- Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00302757
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Medical Center Charite Benjamin Franklin Berlin, Germany
- University of Dresden Medical Center Dresden, Germany
- Center for Marrow Transplantation, University of Essen Essen, Germany
- Medical Center University of Goettingen Göttingen, Germany
NCT00306111
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Dept. of Medicine 2, University of Tuebingen Tübingen, Baden-Wurttemberg, Germany
Completed
Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma
NCT00054639
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +60 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00177190
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States